Non-muscle Invasive Bladder Cancer Clinical Trials in Dallas, Texas

5 studies are recruiting for non-muscle invasive bladder cancer in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

   The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Specifically, this study examines whether there are any differences in urinary symptoms, discomfort, number of invasive procedures, anxiety, com…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   UT Southwestern Medical Center, Dallas, Texas

   Locations

   10 in total

   Run by

   White River Junction Veterans Affairs Medical Center

   See if you can join NCT05796375 on ClinicalTrials.gov

2. A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

   The purpose of this study is to learn how a new medicine called PF-08052667 works when used by itself or together with another medicine called Bacillus Calmette Guerin (BCG), and/or a medicine called sasanlimab. This study is for adults who have a type of bladder cancer that hasn't spread into the …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Cancer Center Outpatient Building, Dallas, Texas

   Locations

   68 in total

   Run by

   Pfizer

   See if you can join NCT07206225 on ClinicalTrials.gov

3. Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

   This is a multi-center study and the aim is to develop and validate an Artificial Intelligence (AI) -based histologic analysis tool to predict responsiveness to intravesical Bacillus Calmette-Guérin (BCG) and intravesical chemotherapy in intermediate and high-risk non-muscle invasive bladder cancer…

   Stage

   Not phased

   Ages

   18 to 99

   Site

   University of Texas Southwestern Medical Center, Dallas, Texas

   Locations

   2 in total

   Run by

   University of Texas Southwestern Medical Center

   See if you can join NCT05825950 on ClinicalTrials.gov

4. LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

   This study will evaluate the safety and efficacy of intravesical administration of detalimogene (EG-70) in the bladder and its effect on bladder tumors in patients with NMIBC. This study study consists of two phases; a Phase 1 dose-escalation to establish safety and recommended the phase 2 dose, fo…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   UT Southwestern Medical Center, Dallas, Texas

   Locations

   102 in total

   Run by

   enGene, Inc.

   See if you can join NCT04752722 on ClinicalTrials.gov

5. A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

   This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment, dose escalation and expansion study designed to determine the safety and tolerability of STM-416 in patients with bladder cancer.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   University of Texas Southwestern Medical Center, Dallas, Texas

   Locations

   20 in total

   Run by

   SURGE Therapeutics

   See if you can join NCT05710848 on ClinicalTrials.gov